The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS–a critical overview
HG Bernstein, G Keilhoff, H Dobrowolny… - Reviews in the …, 2023 - degruyter.com
Dipeptidyl peptidase 4 is a serine protease that cleaves X-proline or X-alanine in the
penultimate position. Natural substrates of the enzyme are glucagon-like peptide-1 …
penultimate position. Natural substrates of the enzyme are glucagon-like peptide-1 …
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and …
J Du, J Fu, W Zhang, L Zhang… - International …, 2023 - spandidos-publications.com
The worldwide COVID‑19 pandemic was brought on by a new coronavirus (SARS Cov‑2). A
marker/receptor called Dipeptidyl peptidase 4/CD26 (DPP4/CD26) may be crucial in …
marker/receptor called Dipeptidyl peptidase 4/CD26 (DPP4/CD26) may be crucial in …
Discriminating promiscuous from target‐specific autoantibodies in COVID‐19
M Lebedin, CV García, L Spatt… - European Journal of …, 2023 - Wiley Online Library
Diverse autoantibodies were suggested to contribute to severe outcomes of COVID‐19, but
their functional implications are largely unclear. ACE2, the SARS‐CoV‐2 receptor and a key …
their functional implications are largely unclear. ACE2, the SARS‐CoV‐2 receptor and a key …
In-silico investigation of systematic missense mutations of middle east respiratory coronavirus spike protein
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) causes severe pneumonia-
like symptoms and is still pose a significant threat to global public health. A key component …
like symptoms and is still pose a significant threat to global public health. A key component …
Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients
V Schöning, F Hammann - Pharmaceutics, 2022 - mdpi.com
Drug interactions with other drugs are a well-known phenomenon. Similarly, however, pre-
existing drug therapy can alter the course of diseases for which it has not been prescribed …
existing drug therapy can alter the course of diseases for which it has not been prescribed …
Effect of DPP4/CD26 expression on SARS-CoV-2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and …
W Zhang, L Zhang, H Chen… - International Journal of …, 2023 - search.proquest.com
The worldwide COVID-19 pandemic was brought on by a new coronavirus (SARS Cov-2). A
marker/receptor called Dipeptidyl peptidase 4/CD26 (DPP4/CD26) may be crucial in …
marker/receptor called Dipeptidyl peptidase 4/CD26 (DPP4/CD26) may be crucial in …
Exploring the Genetic Landscape of COVID-19 Susceptibility Among Patients in Türkiye: A Variant Discovery Study
Y Çakır - 2024 - search.proquest.com
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has underscored the need to
understand the genetic factors influencing disease susceptibility. This study adopts a data …
understand the genetic factors influencing disease susceptibility. This study adopts a data …